Startups In The Fight Against Cancer: A Venture Capital Perspective

swissnex Boston invites you to a special event that will bring together a transatlantic panel of experienced VCs and entrepreneurs, who have launched ventures aimed at developing new therapies against cancer.

Event Details

Location

swissnex Boston
420 Broadway, Cambridge , Massachusetts 02138 United States

Date

September 24, 2014 from 10:30 pm to 12:30 am Pacific/Easter (UTC-05:00)

swissnex Boston invites you to a special event that will bring together a transatlantic panel of experienced VCs and entrepreneurs, who have launched ventures aimed at developing new therapies against cancer. This panel will bring different perspectives encompassing the latest trends in oncology and the factors that are crucial for an early stage startup.

Come join us  for an engaging conversation with a group of international experts in the biotech arena, followed by a lively reception including hors d’oeuvres and refreshments.


Panelists:

  • Moderator: Steven Dickman, CEO of CBT Advisors

  • Jeffrey Albers, CEO of Blueprint Medicines

  • Alfred Scheidegger, CEO of Nextech Invest

  • Oliver Middendorp, CBO and CEO of Numab

  • Doug Cole, General Partner of Flagship Ventures

Top